Tag: lab acquisition

December 3, 2018 Intelligence: Late Breaking Lab News

By Robert Michel, from the Volume XXV No. 17 – December 3, 2018 issue

Another long-established regional laboratory company is about to be acquired. On November 27, Boyce and Bynum Pathology Laboratories of Columbia, Mo., disclosed that it had entered an agreement to be acquired by Quest Diagnostics Inc. Notably, the press release about the agreement states that the anatomic pathology division, Boyce and Bynum Professional Services, Inc., and the

View Article

Sale of Tox Lab Company Attracted Multiple Buyers

By Joseph Burns, from the Volume XXV No. 4 – March 5, 2018 issue

CEO SUMMARY: In the midst of expanding their toxicology testing services nationally, DrugScan and DSI Medical Services (collectively Toxicology Holdings Inc.) hired a brokerage firm last year to pursue a sale of the two toxicology companies. Multiple potential buyers responded with interest. The buyer, ACM Global Laboratories—owned by a health system in Rochester, N.Y.—saw the

View Article

Lab Acquisitions: LabCorp, Quest, Sonic Do Hospital Lab Deals

By Bill Dugan, from the Volume XXIV, No. 4 – March 13, 2017 issue

This is an excerpt from a 1,021-word article in the March 13, 2017, issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group.
CEO SUMMARY: Is this year’s early spate of deals involving the sales of hospital lab outreach

View Article

Accumen Acquires Chi To Beef Up Lab Consulting

By Joseph Burns, from the Volume XXIII No. 5 - April 11, 2016 issue

CEO SUMMARY: Two different business models of clinical laboratory consulting have now been brought together. Chi consultants have long focused on analytics and improving outreach performance, among other areas of lab performance. By contrast, Accumen’s business model is nontraditional and centers upon a shared-savings partnership with a hospital or health system. Executives at Accumen are betting that a combination of both types

View Article

A Pantheon of Greatest Lab Physician-Businessmen

By R. Lewis Dark, from the Volume XXIII No. 4 – March 21, 2016 issue

WHEN IT COMES TO THE CLINICAL LABORATORY BUSINESS, generally included in the lab industry’s Pantheon of Greatest Physician (Pathologist) Businessmen are Paul A. Brown, MD, and James B. Powell, MD. I’d like to nominate another physician to this list: Marc D. Grodman, MD.

During the 1970s and 1980s, Brown and Powell—both pathologists— founded and led two

View Article

LabCorp Now Larger than Quest, Two Labs Report 2015 Earnings

By Robert Michel, from the Volume XXIII No. 3 – February 29, 2016 issue

IN RECENT WEEKS, the nation’s two largest lab companies reported fourth quarter and full-year earnings for 2015. The earnings reports reveal how the paths of the two companies are diverging.

The companies are diverging because of a major acquisition made in February 2015, by Laboratory Corporation of America. LabCorp bought Covance Inc. in a deal valued at

View Article

LabCorp, Quest Diagnostics Both Say 2014 Revenue Was Up

By Robert Michel, from the Volume XXII NO. 5 - March 30, 2015 issue

BOTH OF THE NATION’S LARGEST clinical laboratory companies reported increased specimen volume as a result of the Accountable Care Act (ACA), as noted in their respective fourth quarter and full-year earnings reports.

View Article

Is PAML to Be Sold? ‘No Comment!’ Say Execs

By Robert Michel

CEO SUMMARY: It is one of the 10 largest lab companies in the United States. Thus, if Pathology Associates Medical Laboratories in Spokane, Washington, were to be sold, it would trigger a major shift in the competitive market for lab testing services-both in the Pacific Northwest and nationally. Owners and executives at PAML have neither confirmed nor denied the ongoing rumors

View Article

February 3, 2014 “Intelligence: Late Breaking Lab News”

By Robert Michel, from the Volume XXI NO. 2 – February 3, 2014 issue

Last month, it was announced that Solstas Lab Partners of Greensboro, North Carolina, had agreed to be sold to Quest Diagnostics Incorporated. The sales price is $570 million and financial analysts on Wall Street estimate that the annual revenue at Solstas Lab Partners is about $350 million. This would indicate that Quest Diagnostics paid a

View Article

Hospital System Acquires Labs In ACO Strategy

By Joseph Burns, from the Volume XX No. 9 - July 8, 2013 issue

CEO SUMMARY: Moving to deliver services as an accountable care organization (ACO), Genesis Health System of Davenport, Iowa, has acquired the laboratory assets in two hospitals previously operated by Metropolitan Medical Laboratory, PLC, a lab company owned by local pathologists. Genesis aims to improve data integration to support CPOE. It also plans to pursue cost

View Article

Volume XXV No. 17 – December 3, 2018

DID CONGRESS JUST PASS A LAW that makes innocent labs guilty of criminal acts? At the last minute, Congress added all clinical laboratories to a far-reaching anti-kickback provision in the newly-enacted Support for Patients and Communities Act -- a provision that makes common practices such as paying commissions to sales staff or placing phlebotomists in labs could be illegal. Worse: The experts are baffled by the language of the new law. Notes one of these experts in this issue, "Someone in the clinical lab industry may have to get prosecuted before we get some clarity, unless the Secretary of HHS issues clarifying regulations."

See the full table of contents

Tag: lab acquisition

Enter Your Login Credentials